Dr. Nguyen Ngo Quang - Deputy Director of Department of Science and Technology and Training, Ministry of Health said, Vietnam has 3 technological transfer contracts related to Vaccine Covid-19 with Russia, USA, Japan signed. Linking.Vabiotech has built a sputnik-v.theo vaccine tube, Vababiotech and international progressive joint stock company (AIC) and Shionogi Japan company, signed a technology transfer agreement to produce Covid-19 vaccine
. Vaccine technology is transferred as Recombinant SARS-COV-2 spike protein (Baculovirusexpression vector system), is the recombinant vaccine production technology. Currently the parties signed a security agreement to access Vaccine and Technology. Before that, on May 7, 2021, the Minister of Health issued Decision No
2301 / QD-BYT established the Steering Committee Research on technology transfer and production of Covid-19 room vaccine, for technology transfer cooperation project between AIC Company and Shionogi Company (Japan) and Vaccine according to MNRA technology, now The Ministry of Health has signed a cooperation agreement and is preparing a plan to implement phase 3 clinical trial research in Vietnam with a clue is a central epidemic hygiene institute. At the same time, doing technology transfer procedures with the clues are Vaccine and Bioms Limited Company No. 1 (Vabaotech). Opening of June 2022 will complete the activities and take the vaccine to the market. With the project Technology transfer between DS-Bio Company, Vaccine and Biological Company Limited No. 1 (Vabaotech) and the Russian Federal Direct Investment Fund, Vietnam signed an agreement with the direct investment fund of the Russian Federation About closing the sputnik-v vaccine tube from semi-finished products.Vabiotech has built a pipe and sending samples to the Russian Federation to inspect quality, expected to 10/8 will have the following verification results can be carried out Closing the tube with a size of 5 million doses per month (in August 2021 can begin with a minimum of 500,000 doses), proceeding to transfer production technology with a scale of 100 million doses per year. For research projects Save technology transfer with the US, currently the Ministry of Health has sent a group of experts to coordinate with the World Health Organization WHO supporting the relevant unit to complete the phase 1 clinical trial record - 2-3 According to the shortened process, it is expected to start research on August 1 and end at the end of December 2021. Technology transfer and finishing the vaccine factory in Vietnam will be completed in June /2022. Tran Nguyen
Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
